Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q13613
UPID:
MTMR1_HUMAN
Alternative names:
Phosphatidylinositol-3,5-bisphosphate 3-phosphatase; Phosphatidylinositol-3-phosphate phosphatase
Alternative UPACC:
Q13613; A0A024RC07; Q9UBX6; Q9UEM0; Q9UQD5
Background:
Myotubularin-related protein 1, known for its specificity towards phosphatidylinositol 3-phosphate, plays a crucial role in lipid phosphatase activity, distinguishing itself by not acting on other phosphatidylinositols. This protein, alternatively named Phosphatidylinositol-3,5-bisphosphate 3-phosphatase and Phosphatidylinositol-3-phosphate phosphatase, is pivotal in cellular processes.
Therapeutic significance:
Understanding the role of Myotubularin-related protein 1 could open doors to potential therapeutic strategies, offering new avenues for drug discovery and development in targeting lipid-related disorders.